Halozyme Therapeutics, Inc. (HALO)
NASDAQ: HALO · Real-Time Price · USD
71.48
+0.75 (1.06%)
At close: Jun 9, 2026, 4:00 PM EDT
71.04
-0.44 (-0.61%)
After-hours: Jun 9, 2026, 6:05 PM EDT
Halozyme Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst J.P. Morgan No rating | J.P. Morgan | Hold Maintains $70 | Hold | Maintains | $70 | -2.07% | May 20, 2026 |
| Wells Fargo | Wells Fargo | Hold Maintains $75 | Hold | Maintains | $75 | +4.92% | May 14, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Reiterates $93 | Buy | Reiterates | $93 | +30.11% | May 12, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $95 | Buy | Reiterates | $95 | +32.90% | May 12, 2026 |
| TD Cowen | TD Cowen | Buy Maintains $96 | Buy | Maintains | $96 | +34.30% | May 11, 2026 |
| Benchmark Co. | Benchmark Co. | Buy Maintains $75 → $90 | Buy | Maintains | $75 → $90 | +25.91% | Feb 19, 2026 |
| Leerink Partners | Leerink Partners | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Jan 8, 2026 |